Drug intelligence / Profile preview

Trenmix

Development stage
Unknown
Lead developer
Endava
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Trenmix is an injectable anabolic-androgenic steroid (AAS) blend developed by DEK Pharma, typically containing a combination of three trenbolone esters: trenbolone acetate, trenbolone hexahydrobenzylcarbonate, and trenbolone enanthate. This formulation is designed to provide a multi-stage release profile, offering both rapid onset and prolonged activity of the potent androgen trenbolone. Trenbolone acts as a high-affinity agonist of the androgen receptor, significantly enhancing protein synthesis, nitrogen retention, and muscle mass while exhibiting strong anti-catabolic effects by antagonizing glucocorticoid receptors. While trenbolone derivatives are used in veterinary medicine to increase livestock efficiency, Trenmix is primarily marketed for physique and performance enhancement and is not approved for human therapeutic use by major regulatory agencies like the FDA.

Brand names
TrenmixTrenmix 150Trenmix150Trenmix-150
Other names
Trenbolone MixTrenbolone BlendTrenbolone Tri-ester
02

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on Trenmix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trenmix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call